Company intelligence / Profile preview

Galenicum Derma

San Agustin del Guadalix, Madrid, Spaingalenicum.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Galenicum Derma develops, in-licensees, and markets innovative high-quality dermatological products. Its sales team covers the Spanish national market with plans for international expansion. No clinical trial data or results are publicly available as the focus appears to be on commercialized products rather than novel drug development.

Therapeutic areas: Dermatology
Modalities: Topical formulations (creams, ointments)possibly small molecules for dermatological use
Industry: Biotech

Partnerships

In-license agreements for innovative/high-quality dermatological products; considering third-party distribution deals for international expansion.

Beyond the preview

Go deeper on Galenicum Derma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galenicum Derma.

Explore the full profile